The promoter and 5' flanking sequences controlling human B29 gene expression
- PMID: 8555489
The promoter and 5' flanking sequences controlling human B29 gene expression
Abstract
The product of the B-cell-specific B29 gene (B29, Ig beta, CD79b) is essential for Ig-mediated B-cell activation via the B-cell antigen receptor complex (BCR) on human and murine B lymphocytes. To better understand the regulation of this pivotal gene, we have analyzed the human genomic DNA sequence upstream of the B29 ATG start codon for transcriptional control activity. The human B29 gene lacks either a TATA or a CAAT box and transcription is initiated at multiple sites. The minimal promoter of the human B29 gene is contained within a 193-bp region 5' of these multiple start sites. This minimal promoter exhibits B-cell-specific activity and contains SP1, ETS, OCT, and IKAROS/LYF-1 transcription factor motifs. All these motifs are strikingly conserved in sequence and placement relative to the previously characterized murine B29 promoter. Additional upstream gene segments dramatically affected B29 minimal promoter activity. A newly identified motif called the B29 conserved sequence (BCS), found upstream of both human and murine B29 promoters, appears to stimulate B29 transcription through a novel mechanism. A single BCS had little effect either on the minimal B29 promoter or on a heterologous promoter. Instead, the BCS stimulated transcription by counteracting 5' negative regulatory DNA sequences that block the activity of the B29 minimal promoter in its absence. These findings indicate that B29 gene expression is controlled by the complex interplay of positive and negative regulatory elements.
Similar articles
-
A conserved sequence upstream of the B29 (Ig beta, CD79b) gene interacts with YY1.Mol Biol Rep. 2004 Mar;31(1):1-11. doi: 10.1023/b:mole.0000013489.04734.5e. Mol Biol Rep. 2004. PMID: 15040449
-
Silencer elements controlling the B29 (Igbeta) promoter are neither promoter- nor cell-type-specific.Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12314-9. doi: 10.1073/pnas.94.23.12314. Proc Natl Acad Sci U S A. 1997. PMID: 9356446 Free PMC article.
-
Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.J Immunol. 2002 Apr 1;168(7):3369-75. doi: 10.4049/jimmunol.168.7.3369. J Immunol. 2002. PMID: 11907094
-
An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression.J Immunol. 2000 Mar 1;164(5):2550-6. doi: 10.4049/jimmunol.164.5.2550. J Immunol. 2000. PMID: 10679093
-
Multiple motifs regulate the B-cell-specific promoter of the B29 gene.Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11723-7. doi: 10.1073/pnas.90.24.11723. Proc Natl Acad Sci U S A. 1993. PMID: 8265616 Free PMC article.
Cited by
-
Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.Mol Cell Biol. 1999 Apr;19(4):2601-12. doi: 10.1128/MCB.19.4.2601. Mol Cell Biol. 1999. PMID: 10082526 Free PMC article.
-
B29 gene silencing in pituitary cells is regulated by its 3' enhancer.J Mol Biol. 2006 Sep 15;362(2):173-83. doi: 10.1016/j.jmb.2006.07.046. Epub 2006 Jul 28. J Mol Biol. 2006. PMID: 16920149 Free PMC article.
-
A conserved sequence upstream of the B29 (Ig beta, CD79b) gene interacts with YY1.Mol Biol Rep. 2004 Mar;31(1):1-11. doi: 10.1023/b:mole.0000013489.04734.5e. Mol Biol Rep. 2004. PMID: 15040449
-
Modulation of eIF5A expression using SNS01 nanoparticles inhibits NF-κB activity and tumor growth in murine models of multiple myeloma.Mol Ther. 2012 Jul;20(7):1305-14. doi: 10.1038/mt.2012.94. Epub 2012 May 15. Mol Ther. 2012. PMID: 22588272 Free PMC article.
-
The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor.Mol Cell Biol. 1999 Jan;19(1):392-401. doi: 10.1128/MCB.19.1.392. Mol Cell Biol. 1999. PMID: 9858563 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases